NCT01348451View on ClinicalTrials.gov

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

PHASE1UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DEVICE

surgical implantation

human spinal cord stem cell implantation in ALS patients

Trial Locations (1)

30322

Emory University, Atlanta

Sponsors

Lead Sponsor

Neuralstem Inc.
All Listed Sponsors
lead

Neuralstem Inc.

INDUSTRY